Fibroblasts are flat, spindle-shaped cells with multiple stellate processes and an extensive rough endoplasmic reticulum1,2. An average fibroblast measures 30 - 100 µm and has a life span of 57 ± 3 days1,3. The average cell cycle duration of human fibroblasts ranges from 16 - 48 h depending on the culture conditions4. There is evidence that the replicative capacity and functional quality of cultured primary fibroblasts negatively correlates with the donor age, suggesting that younger donors (animals or patients) should be preferred if possible5,6.
Fibroblasts constitute a predominant cell type of most mammalian body tissues. Despite their ubiquitous presence, the molecular identification of fibroblasts is still a challenge7. Fibroblasts migrate to developing tissues and organs from different sources during embryonic development8. For this reason, there is a plethora of marker proteins that can be found in fibroblasts whereas unique marker proteins, which are present in every fibroblast population and exclusive for fibroblasts, are still missing. Thus, expression patterns of several recognized markers are usually used to identify fibroblasts. Among the most recognized markers are vimentin, human fibroblast surface protein (hFSP), discoidin domain receptor 2 (DDR2) and alpha smooth muscle actin (αSMA).
Fibroblasts are the major extracellular matrix (ECM)-producing cell type. Thereby, fibroblasts maintain an orderly tissue architecture and provide mechanical support for neighboring cells1. The balance between ECM synthesis and degradation is a well-regulated process. Shifts towards synthesis mark the beginning of excessive ECM deposition which, if not terminated, leads to fibrosis. Fibrosis is mediated by myofibroblasts, which originate from activated fibroblasts undergoing molecular and phenotypical changes. One hallmark of myofibroblasts is enhanced secretion of ECM and cytokines and the expression of orderly arranged αSMA microfilaments9.
Primary fibroblasts have been in the spotlight of recent research focusing on fibrosis, tissue inflammation and fibroblast-cancer-cell interactions10,11. However, to effectively study fibroblast properties in health and disease, it is necessary to isolate viable primary adult fibroblasts on a regular basis. There are several methods available to isolate fibroblasts12,13,14. The three major methods of fibroblast isolation are outgrowth from tissue chunks12, enzymatic tissue digestion15, and enzymatic perfusion of hollow organs9,13,16. The advantage of outgrowth is a gentle isolation process without enzymatic cell degradation. On the other hand, outgrowth cultures usually require prolonged culture periods until cells can be used for experiments. Common enzymatic digestion is fast but bears a risk of contamination with other cell types (e.g., endothelial cells) or bacteria in the agitation process, which is necessary to mechanically dissolve the tissue. Furthermore, these methods are often elaborate and require time and skill to learn.
Regarding the importance of primary fibroblasts in research, there is still a need to optimize existing cell isolation approaches in terms of quickness, simplicity and reliability. Here, a novel ultrasonic-based enzymatic fibroblast isolation method delivering high quality cells is provided.